"The PRIME Act is crucial to the long-term health of American men," said Rep. Dan Burton (R-IN). "We know that when detected and treated early, prostate cancer has a cure rate of over 90 percent. It is time for the federal government to make an investment in the technology that will give physicians the tools they need to end blind patient care."
"This legislation is a prime example of how taxpayer dollars, put to the right use, can positively impact millions of lives and eliminate billions of dollars from an already strained health care system. Prostate cancer is an epidemic in this country and we have a moral imperative to effectively address this health care crisis impacting men and in particular, the African-American male," said Rep. Wynn.
The AdMeTech Foundation is a non-profit organization dedicated to improved early diagnosis and treatment of prostate cancer. The organization develops strategic partnerships with academia, advocacy, industry, and government to facilitate development and implementation of accurate, affordable accessible diagnostic tools for prostate cancer. For more information, log onto http://www.admetech.org or http://www.manogram.org.
(1) Note: The signatories of the letter included Reps. Cummings (D-MD), Burton (R-IN), Clay (D-MO), Crowley (D-NY), Davis (D-IL), Ferguson (R-NJ), Gonzalez (D-TX), Hinojosa (D-TX), Holden (D-PA), Lee (D-TX), LoBiondo (R-NJ), Marshall (D-GA), McGovern (D-MA), Meeks (D-NY), Norton (D-DC), Ortiz (D-TX), Thompson (D-MS), Towns (D-NY), Wynn (D-MD), Fortuno (D-PR) and Green (D-TX).
|SOURCE AdMeTech Foundation|
Copyright©2008 PR Newswire.
All rights reserved